Nicorette Patch Áttetsző (Nicotine)

Nicotine, the active ingredient in Nicorette Patch Áttetsző, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers manage withdrawal symptoms and cravings during attempts to quit smoking and supports a gradual reduction in nicotine dependence under medical guidance.

GNH USA supplies Nicorette Patch Áttetsző as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. The company provides reliable logistics and documentation to meet the requirements of diverse health‑care markets.

Nicotine delivered via the Nicorette Patch is employed in nicotine replacement therapy to assist individuals who wish to stop using tobacco. - Smoking cessation: provides a steady nicotine supply to reduce cravings and withdrawal symptoms, facilitating the quit attempt. - Tobacco dependence: helps transition smokers to lower nicotine levels, supporting gradual reduction of nicotine intake. - Relapse prevention: maintains low nicotine exposure to decrease the likelihood of returning to regular smoking. - Nicotine withdrawal management: alleviates irritability, anxiety, and concentration difficulties associated with abrupt nicotine discontinuation.

The Nicorette Patch may cause adverse reactions, most of which are related to the skin or systemic nicotine exposure.

Common Side Effects: - Skin irritation: redness, itching, or rash at the application site. - Sleep disturbance: difficulty falling asleep or staying asleep. - Vivid dreams: unusually intense or memorable dreams. - Headache: mild to moderate headache during use. - Nausea: mild stomach upset. - Dizziness: light‑headed feeling.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or difficulty breathing. - Severe skin reaction: blistering or necrosis at the patch site. - Chest pain: unexpected chest discomfort that may indicate cardiovascular stress. - Rapid heart rate: tachycardia. - Severe hypotension: low blood pressure.

When using the Nicorette Patch, certain precautions should be observed to ensure safety and effectiveness. - Cardiovascular assessment: evaluate patients with heart disease before initiating therapy. - Lowest effective dose: start with the smallest patch strength appropriate for the smoker’s level of dependence. - Avoid dual nicotine: do not combine with other nicotine replacement products or smoking. - Monitor skin: inspect the application site regularly for irritation or allergic response. - Pregnancy and lactation: use only if the potential benefit outweighs unknown risks. - Store at room temperature: keep in the original packaging, protect from moisture and direct heat.

Nicotine can interact with other medicines, altering their effects or increasing the risk of adverse events.

Major Interactions (Avoid): - Concomitant nicotine products: using other nicotine replacement therapies or smoking while on the patch can cause nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): combined use may increase blood pressure and risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - CYP1A2 substrates: drugs such as theophylline, clozapine, and olanzapine may have reduced plasma levels due to enzyme induction. - Warfarin: nicotine may enhance anticoagulant effect, requiring more frequent INR monitoring. - Insulin and oral hypoglycemics: nicotine can affect glucose metabolism, potentially necessitating dose adjustments.